Trials / Unknown
UnknownNCT03880604
Triple Tourniquets With or Without Tranexamic Acid for Reducing Blood Loss at Open Myomectomy
Triple Tourniquets With or Without IV Tranexamic Acid for Reducing Blood Loss at Open Myomectomy: A Double-blinded Randomized Placebo-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators will investigate the effectiveness of an intravenous tranexamic acid plus triple tourniquets compared with triple tourniquets alone for the reduction of blood loss at the time of myomectomy
Detailed description
An RCT investigated the efficacy of intravenous tranexamic acid (TA) during abdominal myomectomy. The study was unable to demonstrate any significant impact on blood loss, duration of surgery or need for blood transfusionHemostatic tourniquets to reduce intra-operative bleeding have long been available, but data on their efficacy from controlled trials are lacking. The investigators set out to evaluate the use of triple tourniquets plus tranexamic acid in controlled conditions and for the first time to investigate the hypothesis that adding tranexamic acid to tourniquet around the uterine artery reduces postoperative bleeding from the uterine incisions, a well-recognized sequel to surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Triple tourniquets | A number 1 polyglactin suture was tied around the cervix to occlude the uterine arteries, and polythene tourniquets were tied around the infundibulopelvic ligament to obstruct the ovarian vessels |
| DRUG | TA | 1-gram tranexamic acid (10 ml) in 100 ml saline infusion |
| OTHER | placebo to TA | placebo to 1-gram tranexamic acid (10 ml) in 100 ml saline infusion |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2021-03-30
- Completion
- 2021-07-01
- First posted
- 2019-03-19
- Last updated
- 2019-05-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03880604. Inclusion in this directory is not an endorsement.